As part of its ongoing transformation, Solvay announces today that it has signed an agreement to acquire privately-held Chemlogics for a total cash consideration of $1.345 billion. Adding the U.S.-based company to Solvay's Novecare business
See full press release
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in